PANG / Themes ETF Trust - Leverage Shares 2X Long PANW Daily ETF - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 panacea8kresignationandappoi.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 15, 2016 Panacea Global, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other j

September 17, 2015

Converted by EDGARwiz Exhibit 16.1 September 17, 2015 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Panacea Global, Inc.?s Form 8-K dated September 15, 2015, and we are in agreement with the statements concerning our firm contained therein. We have no basis to agree or disagree with any other matters reported therein

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Exhibit 3.1- Certificate of Amendment

EX-3.1 2 exhibit31.htm EXHIBIT 3.1 Exhibit 3.1- Certificate of Amendment

Panacea Global NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 000-30424 CUSIP NUMBER (Check one): ýForm 10-K o Form 20-F o Form 11-K ¨Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2

Option Agreement

Converted by EDGARwiz Option Agreement This Option Agreement to obtain the majority control of the Sublicense Holder ("Agreement"), dated as of February 24, 2015 ("Effective Date"), is by and between Panacea Pharma Inc.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 panaceaglobal8kreusrightsmar.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2015 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or oth

DISTRIBUTOR AGREEMENT

DISTRIBUTOR AGREEMENT THIS AGREEMENT is made this 23th day of January, 2015 (Effective Date), by and between Panacea Global Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Panacea Global FORM 10-Q (Quarterly Report)

10-Q 1 wppgisept1410q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

September 25, 2014

Chapter 35, Appendix 2 – 35A2 September 25, 2014 Securities and Exchange Commission 100 F Street N.

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

8-K 1 panacea8kitems401and901septe.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2014 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or oth

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACE

Panacea Global Corporate Overview Spring 2014

EX-99.1 22 panaceaglobalcorporateovervi.htm CORPORATE OVERVIEW SLIDES, SPRING 2014 Panacea Global Corporate Overview Spring 2014

Financial Statements and Exhibits, Other Events

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

EMPLOYMENT SERVICES AGREEMENT

Exhibit 10.3 EMPLOYMENT SERVICES AGREEMENT This Employment Services Agreement (the “Agreement”) is entered into as of the 17 day of April , 2014, by and between Panacea Global, Inc., a Nevada corporation, with a business address of 330 High Way #7 East, Suite #502, Richmond hill, Ontario, L4B3P8, Canada. (the “Company”), and Mahmood Moshiri, an individual residing at 47 Brillinger Street, Richmond

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT

Exhibit 10.2 PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT THIS NON-QUALIFIED STOCK OPTION is granted as of April 10, 2014 by PANACEA GLOBAL, INC., a Nevada corporation (the “Company”), to Binnay Sethi (“Optionee”). Recitals: WHEREAS, the Optionee is employed by the Company as its Vice President and Director; WHEREAS, the Company has established the Panacea Global, Inc. 2011 Omnibus In

PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT

Exhibit 10.1 PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT THIS NON-QUALIFIED STOCK OPTION is granted as of April 10, 2014 by PANACEA GLOBAL, INC., a Nevada corporation (the “Company”), to Dr. Mahmood Moshiri (“Optionee”). Recitals: WHEREAS, the Optionee is employed by the Company as its Chief Executive Officer, President, Chief Medical Officer, Interim Chief Financial Officer, and Dir

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA GLOBAL, INC.

1

Converted by EDGARwiz Exhibit 21.1 List of Subsidiaries Panacea Global, Inc., a Delaware corporation Panacea Global, Inc., a corporation organized under the laws of Ontario, Canada 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANAC

- FORM 8-K

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA G

List of Subsidiaries

Exhibit 21.1 List of Subsidiaries Panacea Global, Inc., a Delaware corporation Panacea Global, Inc., a corporation organized under the laws of Ontario, Canada

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 33-0680443 PANACEA GLOBAL, INC.

AMENDMENT NO. 2 TO LICENSE AGREEMENT

AMENDMENT NO AMENDMENT NO. 2 TO LICENSE AGREEMENT This AMENDMENT NO.2 TO LICENSE AGREEMENT (this “ Second Amendment”) dated as of January 18, 2013 (the “Effective Date”) is entered into by and among Panacea Pharmaceuticals, Inc., a corporation organized under the laws of Maryland (“Pharmaceuticals”), having its principal place of business at 209 Perry Parkway, Suite 13, Gaithersburg, MD, and Panac

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2013 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

10-Q 1 panaceaglobalq310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 f8kre09262012pressreleasev2.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2012 PANACEA GLOBAL, INC . (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or ot

World Cancer Congress presentations show that Panacea Global's proprietary HAAH test has high sensitivity and specificity

Converted by EDGARwiz PRESS RELEASE For immediate release PANACEA GLOBAL INC. PANG-OTCBB, NASDAQ Breakthrough Cancer Detection Test Could Soon Be Available in Canada World Cancer Congress presentations show that Panacea Global's proprietary HAAH test has high sensitivity and specificity TORONTO, ONTARIO, Sept. 26, 201 - Canadian healthcare providers could soon have access to a powerful new laborat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA GLOBAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA GLOBAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 33-0680443 PANACEA GLOBAL, INC.

AMENDMENT NO. 1 TO LICENSE AGREEMENT

AMENDMENT NO. 1 TO LICENSE AGREEMENT This AMENDMENT NO.1 TO LICENSE AGREEMENT (this ?Amendment?) dated as of November 18, 2011 (the ?Effective Date?) is entered into by and among Panacea Pharmaceuticals, Inc., a corporation organized under the laws of Maryland (?Pharmaceuticals?), having its principal place of business at 209 Perry Parkway, Suite 13, Gaithersburg, MD, and Panacea Global, Inc. (?Gl

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2011 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization

EX-10.1

-

Panacea Global, Inc. 88 Toporowski Ave., Richmond Hill Ontario, Canada November 30, 2011 VIA EDGAR Duc Dang, Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Panacea Global, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed April 15, 2011 File No. 000-30424 Dear Mr. Dang We are in receipt of your comment letter dated Nov

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA GLOBAL,

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2011 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement x Definitive Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) PANACEA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Definitive Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) PANACEA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-30424 PANACEA GLOBAL, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2011 Panacea Global, Inc. (Exact Name of Registrant As Specified In Charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization) (Commi

PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT

PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT THIS NON-QUALIFIED STOCK OPTION is granted as of July 26, 2011 by PANACEA GLOBAL, INC., a Nevada corporation (the “Company”), to Binnay Sethi (“Optionee”). Recitals: WHEREAS, the Optionee is employed by the Company as its Vice President, Chief Financial Officer and Director; WHEREAS, the Company has established the Panacea Global, Inc. 2011

PANACEA GLOBAL, INC. 2011 OMNIBUS INCENTIVE PLAN

PANACEA GLOBAL, INC. 2011 OMNIBUS INCENTIVE PLAN 1. Purpose. Panacea Global, Inc. (the “Company”) hereby adopts The Panacea Global, Inc. 2011 Omnibus Incentive Plan (the “Plan”), effective as of July 26, 2011. The Plan is intended to recognize the contributions made to the Company by its associates (including associates who are members of the Board of Directors), directors, consultants and advisor

PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT

EX-10.2 3 v230431ex10-2.htm PANACEA GLOBAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT THIS NON-QUALIFIED STOCK OPTION is granted as of July 26, 2011 by PANACEA GLOBAL, INC., a Nevada corporation (the “Company”), to Mahmood Moshiri (“Optionee”). Recitals: WHEREAS, the Optionee is employed by the Company as its Chief Executive Officer, President, Chief Medical Officer, and Director; WHEREAS, the Com

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act Of 1934 PANACEA GLOBAL, INC. (Name of Issuer) COMMON STOCK, $0.001 Par Value Per Share (Title of Class of Securities) (CUSIP Number) PANACEA GLOB

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act Of 1934 PANACEA GLOBAL, INC. (Name of Issuer) COMMON STOCK, $0.001 Par Value Per Share (Title of Class of Securities) 007373103 (CUSIP Number) PANACEA GLOBAL, INC. 88 Toporowski Ave., Richmond Hill Ontario, Canada L4S2V6 (Name, Address and Telephone Number of Person Authorized to Receive Notice

ARTICLE I

MASTERPURCHASEAGREEMENT This MASTER PURCHASE AGREEMENT (?Agreement?) is entered into as of July 5, 2011(the ?Effective Date?) by and between Panacea Global, Inc.

Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited

Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited Ontario, Canada, July 12, 2011 - Panacea Global Inc., (“the Company”) (OTCQB:PANG), a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced that it has signed a multi-year exclusive sales agreem

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2011 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization) (Co

EX-3.1

Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG

EX-99.1 4 v226240ex99-1.htm Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG Ontario, Canada, June 20, 2011 - Panacea Global Inc., (OTCQB:PANG), a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer (“the Company”), today announced the change of the Company’s name as well the change of

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2011 PANACEA GLOBAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File: 000-30424 MONEYLOGIX GROUP, INC. (Exact name of registrant as specifie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 DEFINITIVE SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 DEFINITIVE SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) xDefinitive Information Statement MONEYLOGIX GROUP, INC. (Name of Regi

May 5, 2011 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3010

May 5, 2011 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.

195 Route 9 South, 2nd Floor, Manalapan, NJ 07726 Tel 732 409 1212 Fax 732 577 1188 475 Park Avenue South, 28th Fl., New York, NY 10016 Tel 646 588 5195 Fax 646 619 4494

April 25, 2011 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.

EX-3.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For Fiscal Year Ended December 31, 2010 Commission File #33-0680443 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its charter) Nevada (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-30424 CUSIP NUMBER (Check one): ý Form 10-K  Form 20-F  Form 11-K ¨ Form 10-Q  Form 10-D  Form N-SAR  Form N-CSR For Period Ended: December 31, 2010  Tr

March 25, 2011

March 25, 2011 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.

SUBSCRIPTION AGREEMENT

Exhibit 10.1 SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of February , 2011 by and between Moneylogix Group, Inc., a company organized under the laws of the State of Nevada, (“MLXG” or the “Company”), and the party who is a signatory hereto (the “Subscriber”). RECITALS: WHEREAS, the Company desires to offer and sell (the “Offering”) up to [·] Units, with each u

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2011 Moneylogix Group, Inc. (Exact Name of Registrant As Specified In Charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization)

COMMON STOCK PURCHASE WARRANT No. ______- Issue Date: , 2011

Exhibit 10.2 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATI

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2011 Moneylogix Group, Inc. (Exact Name of Registrant As Specified In Charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation or organization)

February 14, 2011

February 14, 2011 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. 1) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement MONEYLOGI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its c

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-30424 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2010 o Transi

MONEYLOGIX GROUP, INC. 61 BOWAN COURT TORONTO, ONTARIO, CANADA M2K 3A7

MONEYLOGIX GROUP, INC. 61 BOWAN COURT TORONTO, ONTARIO, CANADA M2K 3A7 July 26, 2010 Duc Dang, Attorney/Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3010 Re: Moneylogix Group, Inc. Preliminary Information Statement on Schedule 14C Filed July 16, 2010 File No. 000-30424 Dear Mr. Dang: We are in receipt of your letter dated July

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement MONEYLOGIX GROUP, INC. (Name o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 Thereunder MONEYLOGIX GROUP, INC. (Exact name of registrant a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 Thereunder MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its corporate charter) 000-30424 (Commission File No.) Nevada 33-0680443 (State of Incorporation) (IRS Employer Identification No.) 61

EX-99.2

STOCK PURCHASE AGREEMENT

STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this "Agreement"), dated as of June 30, 2010, is made by and between Moneylogix Group, Inc.

STOCK PURCHASE AGREEMENT AND SHARE EXCHANGE By and among Moneylogix Group, Inc. A Nevada Corporation Panacea Global, Inc. A Delaware Corporation The Shareholders of Panacea Global, Inc. Effective as of June 30, 2010

STOCK PURCHASE AGREEMENT AND SHARE EXCHANGE By and among Moneylogix Group, Inc. A Nevada Corporation And Panacea Global, Inc. A Delaware Corporation And The Shareholders of Panacea Global, Inc. Effective as of June 30, 2010 1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE, made and entered into this 30th day of June, 2010, by and among Moneylogix Group, Inc., a Nevada corporation with its principal

STOCK PURCHASE AGREEMENT

STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this "Agreement") is made effective the 30th day of June, 2010 by and between MAJID HADITAGHI, an individual residing in Richmond Hill, Canada, (the "Seller") who is a majority shareholder of MoneyLogix Group, Inc.

Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 3 FINANCIAL STATEMENTS Balance Sheet 4 Statement of Operations 5 Statement of Cash Flows 6 Statement of Stockholders' Deficit 7 Notes to the Financial Statements 8 - 13

PANACEA GLOBAL, INC. (A Development Stage Company) FINANCIAL STATEMENTS APRIL 30, 2010 1 PANACEA GLOBAL, INC. (A Development Stage Company) APRIL 30, 2010 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 3 FINANCIAL STATEMENTS Balance Sheet 4 Statement of Operations 5 Statement of Cash Flows 6 Statement of Stockholders' Deficit 7 Notes to the Financial Statements 8 - 13 2 REPO

LICENSE AGREEMENT

LICENSE AGREEMENT THIS LICENSE AGREEMENT (the “Agreement”) is made as of March 24, 2010 (the “Effective Date”) between Panacea Pharmaceuticals, Inc.

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2010 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 000-30424 33-0680443 (State or other jurisdiction of incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For Fiscal Year Ended December 31, 2009 Commission File #33-0680443 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its charter) Nevada (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 33-0680443 CUSIP NUMBER (Check one): x Form 10-K  Form 20-F  Form 11-K  Form 10-Q  Form 10-D  Form N-SAR  Form N-CSR For Period Ended: December 31, 2009  Transition Rep

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2009 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 33-0680443 (State or other Jurisdiction of Incorporation) (Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 33-0680443 CUSIP NUMBER (Check one):  Form 10-K  Form 20-F  Form 11-K x Form 10-Q  Form 10-D  Form N-SAR  Form N-CSR For Period Ended: September 30, 2009  Transition Re

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) x Definitive Information Statement MONEYLOGIX GROUP,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT #1 TO SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT #1 TO SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: [X] Amended Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) [ ] Definitive Informatio

September 9, 2009

September 9, 2009 Mr. Adam F. Turk Securities and Exchange Commission Division of Corporate Finance Washington DC 20549 Re: MoneyLogix Group, Inc. Preliminary Information Statement on Schedule 14C Filed August 31, 2009 File No. 000-30424 Dear Mr. Turk: We represent Moneylogix Group, Inc. (“Moneylogix” or the “Company”). We are in receipt of your letter dated September 9, 2009 and the following set

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) [ ] Definitive Information Statement MONEYLOGIX G

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 24, 2009 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in Charter) Nevada 000-1024048 33-0680443 (State or other jurisdiction of incorporation or organization) (Commission Fi

EX-10.2

EX-10.1

EX-10.3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its char

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) [ ] Definitive Information Statement MONEYLOGIX G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2009 MONEYLOGIX GROUP, INC. (Exact

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2009 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in Charter) Nevada 000-1024048 33-0680443 (State or other jurisdiction of incorporation or organization) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Fo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For Fiscal Year Ended December 31, 2008 Commission File #33-0680443 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its charter) Nevada

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Gary Cilevitz CFO & Corporate Secretary MoneyLogix Group, Inc. 9000 Keele St., Unit 4 Concord, Ontario, L4K 0B3 905-761-1400 [email protected] www.MoneyLogixGroup.com June 5, 2009 Jennifer Monick Senior Staff Accountant Division of Corporation Finance Securities and Exchange Commission Washington, DC 20549 Re: File No. 000-30424 MoneyLogix Group, Inc Dear Ms. Monick: In response to you

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 22, 2009 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in Charter) Nevada 000-1024048 33-0680443 (State or other jurisdiction of incorporation or organization) (Commission File

EX-10.1

MONEYLOGIX ANNOUNCES ACQUISITION OF 100 ACRE DEVELOPMENT PROPERTY ADJACENT TO TORONTO COMMUTER LINK

EX-99.1 45 v150900ex99-1.htm OTC Symbol: MLXG MONEYLOGIX ANNOUNCES ACQUISITION OF 100 ACRE DEVELOPMENT PROPERTY ADJACENT TO TORONTO COMMUTER LINK Concord, Ontario (May 27, 2009): MoneyLogix Group, Inc. (MLXG:OTCBB) today announced that it has acquired a development property totalling approximately 100 acres in Barrie, Ontario adjacent to the GO Train Station which provides daily commuter transit s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its cha

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2009 MONEYLOGIX GROUP, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2009 MONEYLOGIX GROUP, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-1024048 33-0680443 (State or other jurisdiction of incorporation or organization) (Co

MONEYLOGIX GROUP, INC. ANNOUNCES APPOINTMENT OF NEW MANAGEMENT TEAM & BOARD OF DIRECTORS

MoneyLogix Group, Inc. 9000 Keele St., Unit 4 Concord, Ontario, L4K 0B3 905-761-1400 www.MoneyLogixGroup.com OTC Symbol: MLXG MONEYLOGIX GROUP, INC. ANNOUNCES APPOINTMENT OF NEW MANAGEMENT TEAM & BOARD OF DIRECTORS Concord, Ontario (May 14, 2009): MoneyLogix Group, Inc. is pleased to welcome its new Management Team and Board of Directors. Joining the management team are: Mike Knarr, President & CE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its chart

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-30424 CUSIP NUMBER 60539X101 (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File # MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in its c

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 28, 2007 MONEYLOGIX GROUP, INC. (Exact name of registrant as specified in Charter) Nevada 33-0680443 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Em

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS DECEMBER 31, 2007 MONEYLOGIX INC. (A Development Stage Company) DECEMBER 31, 2007 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Cash Flows 4 Statement of Stockholders' Deficit 5 Notes to the Financial Statements 6 - 10 REPORT OF IN

March 31, 2008

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS MARCH 31, 2008 MONEYLOGIX INC. (A Development Stage Company) MARCH 31, 2008 CONTENTS Page FINANCIAL STATEMENTS Balance Sheet 1 Statement of Operations 2 Statement of Cash Flows 3 Notes to the Financial Statements 4 - 7 MONEYLOGIX INC. (A Development Stage Company) BALANCE SHEET March 31, 2008 December 31, 2007 ASSETS Current Assets

Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS 12 MARCH 2008 MONEYLOGIX INC. (A Development Stage Company) 12 MARCH 2008 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT

SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.

Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS 12 MARCH 2008 MONEYLOGIX INC. (A Development Stage Company) 12 MARCH 2008 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT

Amendment No. 3 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

Amendment No. 3 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement MONEYLOGIX GROUP INC. (f/k/a HOMELIFE, INC.) (Name of Registrant As Spe

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626 April 23, 2008 VIA TELEFAX (202)772-9209 Stacie D. Gorman Securities and Exchange Commission 100 F Street N.E. Washington, DC 20549 Re: Moneylogix Group, Inc. (f/k/a Home Life, Inc.) Amendment to Preliminary Information Statement on Schedule 14C File No. 000-30424 Filed April 10, 2008 Dear Ms. Gorman: We represent Moneylogix Gro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended February 29, 2008 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 MONEYLOGIX GROUP INC. F/K/A HOMELIF

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626 April 10, 2008 Securities Exchange Commission Michael McTiernan, Esq. Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Re: HomeLife, Inc. Preliminary Information Statement File No. 000-30424 Filed February 1, 2008 Dear Mr. McTiernan: We represent HomeLife, Inc. (the “Company” or “HomeLife”). We are in receipt of your let

Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS 12 MARCH 2008 MONEYLOGIX INC. (A Development Stage Company) 12 MARCH 2008 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT

Amendment No. 2 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

Amendment No. 2 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement MONEYLOGIX GROUP INC. (f/k/a HOMELIFE, INC.) (Name of Registrant As Spe

Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9

MONEYLOGIX INC. (A Development Stage Company) FINANCIAL STATEMENTS 12 MARCH 2008 MONEYLOGIX INC. (A Development Stage Company) 12 MARCH 2008 CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 FINANCIAL STATEMENTS Balance Sheet 2 Statement of Operations 3 Statement of Stockholders' Deficit 4 Notes to the Financial Statements 5 - 9 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626 March 13, 2008 Securities Exchange Commission Stacie Gorman Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Re: HomeLife, Inc. Preliminary Information Statement on Schedule 14C File No. 0-30424 Filed February 5, 2008 Dear Ms. Gorman: We represent HomeLife, Inc. (the “Company” or “HomeLife”). We are in receipt of your le

Amendment No. 1 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

Amendment No. 1 to SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement HOMELIFE, INC. (Name of Registrant As Specified In Charter) Payment of

ADDENDUM TO AGREEMENT FOR CLARIFICATION OF MATERIAL TERMS DATED JANUARY 3, 2008 BETWEEN HOMELIFE, INC., AGDAS FINANCIAL HOLDING, INC. AND MONEYLOGIX, INC.

ADDENDUM TO AGREEMENT FOR CLARIFICATION OF MATERIAL TERMS DATED JANUARY 3, 2008 BETWEEN HOMELIFE, INC.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2007 HOMELIFE, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-1024048 33-0680443 (State or other jurisdiction of incorporation or o

EX-3.2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2007 HOMELIFE, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-1024048 33-0680443 (State or other jurisdiction of incorporation or o

SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.)

SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2007 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of sma

FORM OF CERTIFICATION PURSUANT TO RULE 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

FORM OF CERTIFICATION PURSUANT TO RULE 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED CERTIFICATIONS I, Marie M.

FORM OF CERTIFICATION PURSUANT TO RULE 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

FORM OF CERTIFICATION PURSUANT TO RULE 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED CERTIFICATIONS I, Andrew Cimerman, certify that: 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2007 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of small

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2007 HOMELIFE, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-1024048 33-0680443 (State or other jurisdiction of incorporation or organization) (Commi

EX-99.I

EX-99.I 2 v095394ex-99i.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2007 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of small b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED MAY 31, 2007 Commission File Number #000-1024048 HOMELI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED MAY 31, 2007 Commission File Number #000-1024048 HOMELIFE, INC. (Name of small business issuer as specified in its charter) Nevada 33-0680443 (State or other jurisdiction of incorporation or organization)

· Printed Material 5 years · Franchise Trademark 20 years · Organization Costs 5 years · Artwork 20 years

August 28, 2007 United States Securities and Exchange Commission Kevin Woody Washington, D.

HomeLife Realty Services, Inc. 1503 South Coast Dr. #204 Costa Mesa, Ca 92626

July 3, 2007 Mr. Kevin Woody Branch Chief United States Securities and Exchange Commission Washington, DC 20549 Dear Mr. Woody: In response to your letter dated June 2, 2007 and in follow up to our phone conversation yesterday, we request an extension of time to file our response to your letter until July 20. 2007. Additionally, as we discussed regarding Exhibit 31.1 and Exhibit 31.2, we have pros

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended February 28, 2007 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of small

HomeLife, Inc. 1503 South Coast Drive, Suite 204 Costa Mesa, CA 92626 714-241-3030 Fax 714-241-8979

August 28, 2006 U.S. Securities and Exchange Commission Washington, D.C. 20549 Attn: Kelly McCusker Re: HomeLife, Inc. Dear Ms. McCusker, This letter is in response to your letter dated July 14, 2006 as a follow up to a previous letter with regards to HomeLife, Inc. financials form 10KSB year ended May, 31, 2005. Comment 1. The first step (Step 1) of a company’s impairment test must be completed w

HomeLife, Inc. 1503 South Coast Drive, Suite 204 714-241-3030 Costa Mesa, CA 92626 Fax 714-241-8979

June 27, 2006 United States Securities and Exchange Commission Division of Corporation Finance Steven Jacobs Branch Chief Washington, D.

HOMELIFE INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2002 [ ] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of s

HOMELIFE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended February 28, 2002 [ ] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act; For the transition period from to Commission File Number #000-1024048 HOMELIFE, INC. (Exact name of s